Hong Kong recalls all supplies of Rotarix
This article was originally published in Scrip
Executive Summary
Following the recent regulatory moves by the US FDA, Hong Kong's department of health has ordered a recall of all stocks and supplies of GlaxoSmithKline's oral rotavirus vaccine Rotarix, and recommended that its local use be suspended.